King's College London at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
King's College London brings 5 presentations to ESGCT 2026 in Hamburg. Its work covers AAV biology and production, from epigenetic and age factors in susceptibility to evolving rep genes for higher yields. Other strands cover ocular gene and cell therapy, base editing for an inherited skin condition and drug-controlled transgene expression.
| Organization | ESGCT 2026 Attendance |
|---|---|
King's College London London, UK | |
Public research university in London with a large health and life sciences faculty. | Workshop Tue Oct 27 12:30pm–1:00pm Disease models, epigenetic and age factors of susceptibility to AAV Vectors and delivery (AAV, lentiviral, LNP) Chair Wed Oct 28 11:00am–12:30pm SESSION 4a: CNS & sensory I Rare and inherited disease Poster Wed Oct 28 1:30pm–3:30pm Towards maximising AAV vector production: in vitro evolution of AAV2 rep genes in HEK293 cells Talk Thu Oct 29 11:45am–1:00pm Ocular gene and cell therapy: an eye on the past whilst looking to the future Rare and inherited diseaseCell therapies and CAR-T Poster Thu Oct 29 2:00pm–4:00pm Adenine Base Editors Effectively Correct Epidermolytic Ichthyosis Genotype and Show Therapeutic Potential in vitro Poster Thu Oct 29 2:00pm–4:00pm Exploration of drug-inducible riboswitches to regulate AAV-delivered transgene expression Vectors and delivery (AAV, lentiviral, LNP) |
Instantly find 20 buyers from King's College London
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction